- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07650162
The Effects of Beta-Alanine Supplementation on Mechanical Performance, Acid-Base Balance, Oxidative Stress, and Enzymatic Antioxidant Defence During Repeated Wingate Anaerobic Tests Under Normoxic and Hypoxic Conditions
Beta-alanine is a dietary supplement that increases skeletal muscle carnosine concentration and may enhance the muscle's ability to buffer hydrogen ions produced during high-intensity exercise. This buffering effect could potentially delay fatigue and improve exercise performance, particularly under conditions that increase metabolic stress, such as hypoxia. However, previous studies examining the effects of beta-alanine supplementation on repeated sprint performance under hypoxic conditions have produced inconsistent findings.
The purpose of this study is to determine whether four weeks of beta-alanine supplementation improves repeated high-intensity cycling performance and influences markers of acid-base balance in trained male cyclists exercising under normoxic and hypoxic conditions. Participants will perform repeated Wingate anaerobic cycling tests before and after a four-week supplementation period with either beta-alanine or placebo.
Mechanical performance outcomes, including peak power, mean power, total work, and fatigue indices, will be assessed alongside physiological measures of metabolic stress, including blood lactate concentration, pH, bicarbonate concentration, and base excess. Performance and physiological responses will be compared between supplementation groups and environmental conditions.
The findings of this study may contribute to a better understanding of the ergogenic potential of beta-alanine supplementation during repeated high-intensity exercise and provide practical information for athletes and practitioners regarding the effectiveness of beta-alanine under conditions of reduced oxygen availability.
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Beta-alanine is a non-essential amino acid and the rate-limiting precursor for the synthesis of carnosine, an intracellular dipeptide found in high concentrations within skeletal muscle. Carnosine contributes to intracellular acid-base regulation by buffering hydrogen ions (H+) produced during high-intensity exercise. Supplementation with beta-alanine has consistently been shown to increase muscle carnosine concentrations, potentially enhancing buffering capacity and delaying the onset of fatigue during exercise characterized by substantial glycolytic energy production.
The ergogenic potential of beta-alanine has been extensively investigated in a variety of exercise modalities. Previous studies and meta-analyses suggest that supplementation may improve performance during high-intensity exercise lasting approximately one to four minutes, where metabolic acidosis is considered an important contributor to fatigue. However, findings remain inconsistent, particularly in exercise protocols involving repeated maximal efforts and in environmental conditions that alter oxygen availability.
Exercise performed in hypoxic environments is associated with reduced oxygen delivery to working muscles, increased reliance on anaerobic glycolysis, accelerated accumulation of hydrogen ions and lactate, and greater disturbance of acid-base homeostasis. Consequently, hypoxic exercise may increase the physiological importance of buffering mechanisms and potentially enhance the relevance of interventions aimed at improving buffering capacity. Despite this theoretical rationale, limited information is available regarding the effectiveness of beta-alanine supplementation during repeated supramaximal exercise performed under hypoxic conditions.
The purpose of this study is to evaluate the effects of four weeks of beta-alanine supplementation on repeated high-intensity cycling performance and physiological responses associated with metabolic acidosis in trained male cyclists. The study utilizes a randomized, double-blind, placebo-controlled design. Participants complete repeated laboratory testing sessions under both normoxic and normobaric hypoxic conditions before and after the supplementation period.
Exercise performance is assessed using a repeated Wingate anaerobic cycling protocol consisting of three consecutive 30-second maximal efforts separated by standardized recovery intervals. The protocol was selected because it induces substantial anaerobic energy production and metabolic stress, allowing evaluation of both performance outcomes and buffering-related physiological responses. Testing is conducted under normoxic conditions and under normobaric hypoxia corresponding to an altitude of approximately 2500 meters above sea level.
Physiological measurements include assessments of blood lactate concentration and indicators of acid-base balance collected in conjunction with the exercise protocol. These measurements are intended to characterize the metabolic and buffering responses to repeated supramaximal exercise and to determine whether beta-alanine supplementation modifies these responses.
The study is designed to improve understanding of the role of beta-alanine supplementation in athletes performing repeated high-intensity exercise under conditions of normal and reduced oxygen availability. The findings may contribute to the evidence base regarding nutritional strategies intended to support performance during repeated maximal efforts and may help clarify whether environmental stressors such as hypoxia influence the ergogenic effectiveness of beta-alanine supplementation.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Katowice, Polen
- Academy of Physical Education in Katowice
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Healthy male participants aged 20-50 years
- Regularly riding a bike (min. 5000 km on the bike in the last year)
- Willingness to maintain habitual dietary and physical activity patterns throughout the study.
- Willingness to refrain from consuming dietary supplements other than those provided as part of the study.
Exclusion Criteria:
- Prevalence of chronic diseases
- β-alanine supplementation within the previous six months
- Use of other dietary supplements, except carbohydrate and whey protein supplements
- Adherence to a vegetarian or vegan diet
- Participation in another clinical trial within the previous 3 months.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Fundamentele wetenschap
- Toewijzing: Gerandomiseerd
- Interventioneel model: Faculteitstoewijzing
- Masker: Verdrievoudigen
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: BA-N
Beta-alanine + normoxia
|
β-alanine (6 g·day-¹)
Andere namen:
normoxic conditions
Andere namen:
|
|
Placebo-vergelijker: PL-N
Placebo + normoxia
|
normoxic conditions
Andere namen:
Placebo (6 g·day-¹)
|
|
Experimenteel: BA-H
Beta-alanine + hypoxia
|
β-alanine (6 g·day-¹)
Andere namen:
Normobaric hypoxic conditions (≈2500 m)
Andere namen:
|
|
Experimenteel: PL-H
Placebo + hypoxia
|
Placebo (6 g·day-¹)
Normobaric hypoxic conditions (≈2500 m)
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Mean Power (W)
Tijdsspanne: 4 weeks
|
4 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Peak Power (W)
Tijdsspanne: 4 weeks
|
4 weeks
|
|
Relative Peak Power (W·kg-¹)
Tijdsspanne: 4 weeks
|
4 weeks
|
|
Total Work (J)
Tijdsspanne: 4 weeks
|
4 weeks
|
|
Fatigue Slope (W·s-¹)
Tijdsspanne: 4 weeks
|
4 weeks
|
|
Rate of Fatigue (%)
Tijdsspanne: 4 weeks
|
4 weeks
|
|
Time to Peak Power (s)
Tijdsspanne: 4 weeks
|
4 weeks
|
|
minimum power (MinP)
Tijdsspanne: 4 weeks
|
4 weeks
|
|
Lactate (mmol·L-¹)
Tijdsspanne: 4 weeks
|
4 weeks
|
|
pH
Tijdsspanne: 4 weeks
|
4 weeks
|
|
BE(B) (mmol·L-¹)
Tijdsspanne: 4 weeks
|
4 weeks
|
|
HCO₃- (mmol·L-¹)
Tijdsspanne: 4 weeks
|
4 weeks
|
Medewerkers en onderzoekers
Onderzoekers
- Studie directeur: Mateusz Gawelczyk, PhD, Institute of Sport Sciences, Academy of Physical Education, 40-065 Katowice, Poland
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Tekenen en symptomen, ademhaling
- Pathologische aandoeningen, tekenen en symptomen
- Tekenen en symptomen
- Hypoxie
- Aminozuren, peptiden en eiwitten
- Fysieke fenomeen
- Anorganische chemicaliën
- Aminozuren
- Elementen
- Ionen
- Elektrolyten
- Gassen
- Elementaire deeltjes
- Kationen, monovalent
- Kationen
- Waterstof
- Nucleonen
- Alanine
- Protonen
- beta-Alanine
Andere studie-ID-nummers
- MGBA
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .